LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

Search

Stevanato Group SpA

Abrir

SetorSaúde

14.33 -0.07

Visão Geral

Variação de preço das ações

24h

Atual

Mín

14.26

Máximo

15.07

Indicadores-chave

By Trading Economics

Rendimento

-2M

47M

Vendas

40M

343M

P/E

Médio do Setor

25.085

57.05

EPS

0.162

Margem de lucro

13.738

Funcionários

6,010

EBITDA

18M

90M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+65.54% upside

Dividendos

By Dow Jones

Próximos Ganhos

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-79M

4B

Abertura anterior

14.4

Fecho anterior

14.33

Sentimento de Notícias

By Acuity

50%

50%

171 / 350 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Stevanato Group SpA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de mar. de 2026, 18:58 UTC

Grandes Movimentos do Mercado

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24 de mar. de 2026, 23:48 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

24 de mar. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24 de mar. de 2026, 23:33 UTC

Conversa de Mercado
Notícias Principais

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24 de mar. de 2026, 23:16 UTC

Conversa de Mercado

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24 de mar. de 2026, 22:40 UTC

Ganhos

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24 de mar. de 2026, 22:40 UTC

Ganhos

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24 de mar. de 2026, 22:40 UTC

Ganhos

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24 de mar. de 2026, 21:44 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

24 de mar. de 2026, 21:44 UTC

Conversa de Mercado

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24 de mar. de 2026, 20:59 UTC

Ganhos

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24 de mar. de 2026, 20:58 UTC

Notícias Principais

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Energy & Utilities Roundup: Market Talk

24 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Basic Materials Roundup: Market Talk

24 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

24 de mar. de 2026, 20:25 UTC

Ganhos

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24 de mar. de 2026, 20:15 UTC

Conversa de Mercado
Notícias Principais

Global Commodities Roundup: Market Talk

24 de mar. de 2026, 20:10 UTC

Conversa de Mercado

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24 de mar. de 2026, 20:10 UTC

Ganhos

Worthington Enterprises 3Q Sales $378.7M >WOR

24 de mar. de 2026, 20:10 UTC

Ganhos

Worthington Enterprises 3Q Adj EPS 98c >WOR

24 de mar. de 2026, 20:10 UTC

Ganhos

Worthington Enterprises 3Q EPS 92c >WOR

24 de mar. de 2026, 19:25 UTC

Conversa de Mercado
Notícias Principais

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24 de mar. de 2026, 19:06 UTC

Conversa de Mercado
Notícias Principais

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24 de mar. de 2026, 18:51 UTC

Conversa de Mercado
Notícias Principais

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24 de mar. de 2026, 18:40 UTC

Conversa de Mercado
Notícias Principais

Global Forex and Fixed Income Roundup: Market Talk

24 de mar. de 2026, 18:40 UTC

Conversa de Mercado
Notícias Principais

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24 de mar. de 2026, 18:34 UTC

Notícias Principais

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24 de mar. de 2026, 18:27 UTC

Conversa de Mercado

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24 de mar. de 2026, 18:21 UTC

Conversa de Mercado
Notícias Principais

Silver Snaps 9-Session Losing Streak -- Market Talk

24 de mar. de 2026, 18:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Comparação entre Pares

Variação de preço

Stevanato Group SpA Previsão

Preço-alvo

By TipRanks

65.54% parte superior

Previsão para 12 meses

Média 24.5 USD  65.54%

Máximo 32 USD

Mínimo 17.5 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Stevanato Group SpA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

4

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

21.56 / 22.61Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

171 / 350 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat